GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹1.90 Cr | ₹2.02 Cr | ₹2.50 Cr | ₹4.54 Cr | ₹1.43 Cr |
What is the latest Total Non-Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹1.90 Cr |
Mar2022 | ₹2.02 Cr |
Mar2021 | ₹2.50 Cr |
Mar2020 | ₹4.54 Cr |
Mar2019 | ₹1.43 Cr |
How is Total Non-Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹1.90 Cr | -5.84 | |
Mar2022 | ₹2.02 Cr | -18.96 | |
Mar2021 | ₹2.50 Cr | -45.06 | |
Mar2020 | ₹4.54 Cr | 218.67 | |
Mar2019 | ₹1.43 Cr | - |
Compare Total Non-Current Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹2,939.6 Cr | -0.9% | 5.2% | 176.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -0.9% |
5.2% |
176.7% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses